Ionis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
IONS Key Statistics
Stock Snapshot
With a market cap of 9.62B, Ionis Pharmaceuticals(IONS) trades at $58.20. The stock has a price-to-earnings ratio of -27.71.
On 2026-07-12, Ionis Pharmaceuticals(IONS) stock moved within a range of $58.18 to $65.32. With shares now at $58.20, the stock is trading +0.0% above its intraday low and -10.9% below the session's peak.
Trading volume for Ionis Pharmaceuticals(IONS) stock has reached 11.44M, versus its average volume of 5.14M.
Over the past 52 weeks, Ionis Pharmaceuticals(IONS) stock has traded between a high of $86.74 and a low of $40.03.
Over the past 52 weeks, Ionis Pharmaceuticals(IONS) stock has traded between a high of $86.74 and a low of $40.03.
IONS News
Ionis Pharmaceuticals (NasdaqGS:IONS) and AstraZeneca reported that their Phase 3 trial of eplontersen in transthyretin mediated amyloid cardiomyopathy did not...
The Motley Fool told its subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005. Stock Advisor still publishes two new stock picks every month —...
• Ionis Pharmaceuticals stock is taking a hit today. What’s pressuring IONS stock? In patients receiving contemporary standard of care, including a majority tr...
Analyst ratings
88%
of 26 ratingsMore IONS News
H.C. Wainwright analyst Mitchell Kapoor lowered the firm’s price target on Ionis Pharmaceuticals (IONS) to $125 from $130 and keeps a Buy rating on the shares....
Wedbush raised the firm’s price target on Intellia Therapeutics to $17 from $12 and keeps a Neutral rating on the shares. Relevant to Intellia Therapeutics (NTL...
The latest update is out from Ionis Pharmaceuticals ( (IONS) ). Ionis Pharmaceuticals reaffirmed its previously announced financial guidance for the fiscal yea...
Analyst Eric Joseph of Citi maintained a Buy rating on Ionis Pharmaceuticals, boosting the price target to $100.00. Unlock powerful investing tools and data-dr...
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
Ionis Pharmaceuticals (IONS) stock was hit hard on Thursday after the biopharmaceutical company provided a clinical trial update. The company and partner AstraZ...
Markets are attempting to recover this morning after Wednesday’s geopolitical-driven selloff, with U.S. stock futures moving modestly higher as oil prices retre...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.